Prevalence and risk factors associated with pulmonary hypertension in HIV-infected patients on regular follow-up

AIDS

Volumn 26, Issue 11, 2012, Pages 1387-1392

  Quezada, Maribel ^a   Martin Carbonero, Luz ^a   Soriano, Vicente ^a   Vispo, Eugenia ^a   Valencia, Eulalia ^a   Moreno, Victoria ^a   De Isla, Leopoldo P ^a   Lennie, Vera ^a   Almería, Carlos ^b   Zamorano, Jose L ^c  

^a HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

^b HOSPITAL CLÍNICO SAN CARLOS   (Spain)

^c HOSPITAL RAMÓN Y CAJAL   (Spain)

Author keywords

echocardiography; HIV; pulmonary arterial hypertension

Indexed keywords

ABACAVIR; ANTIRETROVIRUS AGENT; EMTRICITABINE; HUMAN IMMUNODEFICIENCY VIRUS PROTEINASE INHIBITOR; LAMIVUDINE; NONNUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITOR; TENOFOVIR;

ARTICLE; CARDIOVASCULAR RISK; CD4 LYMPHOCYTE COUNT; DIABETES MELLITUS; DISEASE ASSOCIATION; DOPPLER ECHOCARDIOGRAPHY; DYSLIPIDEMIA; FEMALE; FOLLOW UP; HEART RIGHT VENTRICLE PRESSURE; HEPATITIS B; HEPATITIS C; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MALE HOMOSEXUAL; PRIORITY JOURNAL; PULMONARY HYPERTENSION; RISK FACTOR; SMOKING; SPAIN; VIRUS LOAD;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ADULT; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CD4 LYMPHOCYTE COUNT; COMORBIDITY; DIABETES MELLITUS; FEMALE; HEPATITIS B, CHRONIC; HEPATITIS C, CHRONIC; HIV-1; HUMANS; HYPERTENSION, PULMONARY; MALE; MIDDLE AGED; PREVALENCE; RISK FACTORS; SMOKING; SPAIN; VIRAL LOAD;

EID: 84863724052     PISSN: 02699370     EISSN: 14735571     Source Type: Journal    
DOI: 10.1097/QAD.0b013e328354f5a1     Document Type: Article

References (29)

1. Hammer SM, Eron JJ, Reiss P, Schooley RT, Thompson Ma, Walmsley S, et al. Antiretroviral treatment of adult HIV infection. 2008 recommendations of international AIDS Society-USA panel. JAMA 2008; 300:555-570.
2. Boccara F. Cardiovascular complications and atherosclerotic manifestations in the HIV-infected population: type, incidence and associated risk factors. AIDS 2008; 22 (Suppl 3):S19-S26.
3. Speich R, Jenni R, Opravil M, Pfab M, Russi EW. Primary pulmonary hypertension in HIV infection. Chest 1991; 100:1268-1271.
4. Sitbon O, Lascoux-Combe C, Delfraissy JF, Yeni P, Raffi F, De Zuttere D, et al. Prevalence of HIV-related pulmonary arterial hypertension in the current antiretroviral therapy era. Am J Respir Crit Care Med 2008; 177:108-113.
5. Opravil M, Sereni D. Natural history of HIV-associated pulmonary arterial hypertension: trends in the HAART era. AIDS 2008; 22 (suppl 3):S35-S40.
6. Opravil M, Pechere M, Speich R, Joller-Jemelka H, Jenni R, Russi E, et al. HIV-associated primary pulmonary hypertension. A case control study. Swiss HIV Cohort Study. Am J Respir Crit Care Med 1997; 155:990-995. (Pubitemid 27133414)
7. Degano B, Sitbon O, Simonneau G. Pulmonary arterial hypertension and HIV infection. Semin Respir Crit Care Med 2009; 30:440-447.
8. Nunes H, Humbert M, Sitbon O, Morse JH, Deng Z, Knowles JA, et al. Prognostic factors for survival in human immunodeficiency virus-associated pulmonary arterial hypertension. Am J Respir Crit Care Med 2003; 167:1433-1439. (Pubitemid 36609730)
9. Hsue PY, Deeks SG, Farah HH, Palav S, Ahmed SY, Schnell A, et al. Role of HIV and human herpesvirus-8 infection in pulmonary arterial hypertension. AIDS 2008; 22:825-833. (Pubitemid 351563831)
10. Mesa Ra, Edell ES, Dunn WF, Edwards W. Human Immunodeficiency virus infection and pulmonary hypertension: two new cases and a review of 86 reported cases. Mayo Clin Proc 1998; 73:37-45. (Pubitemid 28063644)
11. Mancia G, De Baker G, Dominiczak A, Cifkova R, Fagard R, Germano G, et al. Guidelines for the management of arterial hypertension: the Task Force for the management of arterial hypertension of the European society hypertension (ESH) and of the European society of cardiology (ESC). J Hypertens 2007; 25:1105-1187. (Pubitemid 46924065)
12. Executive summary. Standards of medical care in diabetes-2011. Diabetes Care 2011; 34(Suppl 1):S4-S10.
13. Reiner Z, Catapano A, De Backer G, Graham I, Taskinen M, Wiklund O, et al. ESC/EAS Guidelines for the management of dyslipidaemias. The Task Force for the management of the dyslipidaemias of the European society of cardiology (ESC) and of the European atherosclerosis society (EAS). Eur Heart J 2011; 32:1769-1818.
14. Rudski L, Lai W, Afilalo H, Hua L, Handschumacher M, Chandrasekaran K, et al. Guidelines for the echocardiographic assessment of the right heart in adults: a report from the American Society of Echocardiography. J Am Soc Echocardiogr 2010; 23:685-713.
15. Mondy K, Gottdiener J, Overton T, Henry K, Bush T, Conley L, et al. High prevalence of echocardiographic abnormalities among HIV-infected persons in the era of highly active antiretroviral therapy. Clin Infect Dis 2011; 52:378-386.
16. Reinsch N, Kahhlert P, Esser S, Sundermeyer A, Neuhaus K, Brockmeyer N, et al. Am J Cardiovasc Dis 2011; 1:176-184.
17. Lederman M, Sereni D, Simonneau G, Voelkel NF. Pulmonary arterial hypertension and its association with HIV infection: an overview. AIDS 2008; 22(Suppl 3):S1-S6.
18. Zuber JP, Calmy A, Evison J, Hasse B, Schiffer V, Wagels T, et al. Pulmonary arterial hypertension related to HIV infection: Improved hemodynamics and survival associated with antiretroviral therapy. Clin Infect Dis 2004; 38:1178-1185. (Pubitemid 38951268)
19. Petureau F, Escamilla R, Hermant C, Mourlanette P, Berjaud J, Krempf M. Pulmonary artery hypertension in HIV seropositive drug addicts. A propos of 10 cases. Rev Mal Respire 1998; 15:97-102.
20. Petipretz P, Brenot F, Azarian R, Parent F, Rain B, Herve P, et al. Pulmonary hypertension in patients with human immunodeficiency virus infection. Comparison with primary pulmonary hypertension. Circulation 1994; 89:2722-2727. (Pubitemid 24173693)
21. Humbert M, Sitbon O, Chaouat A, Bertochi M, Habib G, Gressin V, et al. Pulmonary Arterial Hypertension in France. Results from a National Registry. Am J Respir Crit Care 2006; 173:1023-1033.
22. Valencia E, Ortega M, Guinea J, Laguna F, Moreno V, Gónzalez J. Pulmonary arterial hipertensión in patients with HIVinfection: review of 14 cases. Med Clin (Barc) 2000; 115: 181-184.
23. Mart́n-Carbonero L, Teixeira T, Poveda E, Plaza Z, Vispo E, González-Lahoz J, et al. Clinical and virological outcomes in HIV-infected patients with chronic hepatitis B on long-term nucleos(t)ide analogues. AIDS 2011; 25:1305-1315.
24. Krowka MJ, Plevak DJ, Findlay JY, Rosen CB, Wiesner RH, Krom RA. Pulmonary hemodynamics and perioperative cardiopulmonary-related mortality in patients with portopulmonary hypertension undergoing liver transplantation. Liver Transpl 2000; 6:443-450. (Pubitemid 30489117)
25. Hemmes A, Robbins I. Sildenafil monotherapy in portopulmonary hypertension can facilitate liver transplantation. Liver Transpl 2009; 15:15-19.
26. Grander W, Eller P, Fuschelberger R, Tilg H. Bosentan treatment of portopulmonary hypertension related to liver cirrhosis to hepatitis C. Eur J Clin Invest 2006; 36 (Suppl 3):67-70. (Pubitemid 44179785)
27. Degano B, Guillaume M, Savale L, Montani D, Jaïs X, Azzedine Y, et al. HIV-associated pulmonary arterial hypertension: survival and prognostic factors in the modern therapeutic era. AIDS 2010; 24:67-75.
28. Pelliceli AM, Barbaro G, Palmieri F, Girardi E, D?Ambrosio C, Rianda A, et al. Primary pulmonary hypertension in HIV patients: a systematic review. Angiology 2001; 52:31-41. (Pubitemid 32113205)
29. Degano B, Yaici A, Le Pavec J, Savale L, Jäs X, Camara B, et al. Long term effects of bosentan in patients with HIV-associated pulmonary arterial hypertension. Eur Respir J 2009; 33:92-98.